Valuation
- Market cap
- 1,621,625,000
- Revenue TTM
- $1,342,800,000
- Net income TTM
- $-215,420,000
- PE ratio
- 0.00
- Forward PE
- —
- Profit margin
- -16.04%
- Debt to equity
- 0.80
Trading
- Volume
- 359,700
- Avg volume
- 1,131,342
- Day's range
- $2.25 – $2.50
- Shares out
- 678,504,000
- Stochastic %K
- 91%
- Beta
- 0.74
- Analysts
- Strong Sell
- Price target
- $3.90
Company profile
Curaleaf Holdings, Inc. engages in the retail and wholesale of cannabis products in the United States and internationally. The company operates licensed cultivation; and pharma-grade cannabis processing and manufacturing facilities. It also supplies cannabis on a wholesale basis to Australia, New Zealand, the United Kingdom and various European countries, including Germany, Italy, Poland, the Czech Republic, Switzerl...
Show more
Curaleaf Holdings, Inc. engages in the retail and wholesale of cannabis products in the United States and internationally. The company operates licensed cultivation; and pharma-grade cannabis processing and manufacturing facilities. It also supplies cannabis on a wholesale basis to Australia, New Zealand, the United Kingdom and various European countries, including Germany, Italy, Poland, the Czech Republic, Switzerland, Sweden and Norway. In addition, the company operates a medical cannabis clinic and holds a pharmacy license. It serves the medical and adult-use cannabis markets through retail and wholesale channels. The company is based in Stamford, Connecticut.
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- Website
- https://www.curaleaf.com
- Address
- 290 Harbor Drive, Stamford, United States
Latest news
No headlines yet.
